Glipizide Patent Expiration
Glipizide is used for managing hyperglycemia in diabetes through oral administration of a once-a-day sustained release dosage form of Glipizide. It was first introduced by Pfizer Inc
Glipizide Patents
Given below is the list of patents protecting Glipizide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Glucotrol Xl | US5591454 | Method for lowering blood glucose |
Jan 07, 2014
(Expired) | Pfizer |
| Glucotrol Xl | USRE44459 | Method for lowering blood glucose |
Mar 26, 2019
(Expired) | Pfizer |
Try Our Curated Drug Screens
Glipizide Generics
Several generic applications have been filed for Glipizide. The first generic version for Glipizide was by Aurobindo Pharma Usa Inc and was approved on May 10, 1994. And the latest generic version is by Rubicon Research Private Ltd and was approved on Oct 3, 2023.
Given below is the list of companies who have filed for Glipizide generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Sep 11, 1997 |
| 5MG | tablet | Discontinued | ORAL | N/A | Sep 11, 1997 |
2. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Mar 4, 1996 |
| 5MG | tablet | Discontinued | ORAL | N/A | Mar 4, 1996 |
3. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jun 13, 2001 |
| 10MG
(reference standard) | tablet | Prescription | ORAL | AB | Jun 13, 2001 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, extended release | Prescription | ORAL | AB | May 12, 2017 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | May 12, 2017 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | May 12, 2017 |
5. AUROBINDO PHARMA USA
Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | May 10, 1994 |
| 10MG | tablet | Prescription | ORAL | AB | May 10, 1994 |
6. BARR LABS INC
Barr Laboratories Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 4, 1997 |
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 4, 1997 |
7. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Jun 20, 1995 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 20, 1995 |
8. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Sep 20, 2013 |
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Sep 20, 2013 |
9. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | May 19, 2015 |
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | May 19, 2015 |
| 2.5MG | tablet, extended release | Discontinued | ORAL | N/A | May 19, 2015 |
10. OXFORD PHARMS
Oxford Pharmaceuticals Llc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Oxford Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Nov 28, 1994 |
| 5MG | tablet | Discontinued | ORAL | N/A | Nov 28, 1994 |
11. RUBICON
Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | N/A | Oct 3, 2023 |
| 5MG | tablet | Prescription | ORAL | AB | Oct 3, 2023 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 3, 2023 |
12. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 7, 1995 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 7, 1995 |
13. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Jul 11, 2006 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jul 11, 2006 |
14. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Unique.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, extended release | Prescription | ORAL | AB | Dec 29, 2016 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | Dec 29, 2016 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Dec 29, 2016 |
15. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | Sep 8, 2003 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Nov 7, 2003 |
| 2.5MG | tablet, extended release | Prescription | ORAL | AB | Mar 27, 2006 |
16. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Feb 27, 1995 |
| 5MG | tablet | Prescription | ORAL | AB | Feb 27, 1995 |
17. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet, extended release | Prescription | ORAL | AB | Jul 16, 2018 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | Jul 16, 2018 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jul 16, 2018 |